Products Center

Currently, around 100 different types of autoimmune diseases are known, making them the third largest category of diseases after cardiovascular disease and cancer, affecting about 10% of the global population. Most autoimmune diseases require long-term or even lifelong medication, and there are still no drugs or methods for complete cure.

Cardiovascular disease is the leading cause of death worldwide, accounting for nearly 40% of all deaths. In China, the number of people living with cardiovascular disease has reached 330 million, accounting for nearly a quarter of the total population. As the incidence rate continues to rise, it is imposing a heavy economic burden on patients as well as society.

Respiratory diseases have a high prevalence and mortality rate, with a substantial disease burden. Globally, more than 468 million people suffer from chronic respiratory diseases, including nearly 100 million patients in China. The prevention and control situation is becoming increasingly severe due to factors such as air pollution, smoking, population aging, and the emergence of new and drug-resistant pathogens.

Anti-infectives, as the third largest therapeutic area in China, have a large patient population and significant clinical needs. Currently, the mortality rate from drug-resistant bacterial infections continues to rise, making the promotion of rational antibiotic use and the mitigation of bacterial resistance a pressing public health challenge.